n-Hexyl side chain engineering: Crafting NIR-II AIEgens with balanced fluorescence-photothermal performance for precision tumor ablation
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Innovative Microfluidic and Catalytic Techniques Innovation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. Recent advances and prospects in organic molecule-based phototheranostic agents for enhanced cancer phototherapy
2. A novel acceptor-donor-acceptor structured molecule-based nanosystem for tumor mild photothermal therapy10.1016/j.jcis.2024.05.143 ↗
3. Recent advances in fluorescence imaging-guided photothermal therapy and photodynamic therapy for cancer: from near-infrared-I to near-infrared-II10.1016/j.jconrel.2023.08.056 ↗
4. Recent advances and clinical potential of near infrared photothermal conversion materials for photothermal hepatocellular carcinoma therapy10.1002/adfm.202301138 ↗
5. Organic dyes-based iphotothermal ablation of cancer cells: a review10.1016/j.dyepig.2025.112687 ↗
6. Phototherapy: progress, challenges, and opportunities10.1007/s11426-024-2411-7 ↗
7. From the clinical perspective of photodynamic therapy and photothermal therapy: structure-activity-practice
8. Brain-targeted aggregation-induced-emission nanoparticles with near-infrared imaging at 1550 nm boosts orthotopic glioblastoma theranostics10.1002/adma.202106082 ↗
9. Interstitial optical fiber-mediated multimodal phototheranostics based on an aggregation-induced NIR-II emission luminogen for orthotopic breast cancer treatment10.1002/adma.202406474 ↗
10. Unlocking the NIR-II AIEgen for high brightness through intramolecular electrostatic locking10.1002/anie.202404142 ↗
11. An NIR-II excitable AIE small molecule with multimodal phototheranostic features for orthotopic breast cancer treatment10.1002/adma.202309748 ↗
12. Molecular engineering of AIE luminogens for NIR-II/IIb bioimaging and surgical navigation of lymph nodes10.1016/j.matt.2022.06.030 ↗
13. Molecularly manipulating pyrazinoquinoxaline derivatives to construct NIR-II AIEgens for multimodal phototheranostics of breast cancer bone metastases10.1016/j.biomaterials.2025.123105 ↗
14. Design of superior phototheranostic agents guided by Jablonski diagrams10.1039/D0CS00671H ↗
15. Photothermal agents based on small organic fluorophores with intramolecular motion10.1016/j.actbio.2022.07.004 ↗
16. Near-infrared II hemicyanine dye with large stokes shift designed by TICT regulation for boosting imaging-guided photothermal therapy10.1002/adhm.202301584 ↗
17. An all-rounder for NIR-II phototheranostics: well-tailored 1064nm excitable molecule for photothermal combating orthotopic breast cancer10.1002/anie.202401877 ↗
18. An all-round athlete on the track of phototheranostics: subtly regulating the balance between radiative and nonradiative decays for multimodal imaging-guided synergistic therapy10.1002/adma.202003210 ↗
19. Acceptor/π-bridge planarization and donor rotation manipulation for designing an NIR-II AIEgen with high photothermal conversion efficiency to enhance cancer phototherapy
20. Side-chain engineering of aggregation-induced emission molecules for boosting cancer phototheranostics10.1002/adfm.202107545 ↗
21. Donor engineering for NIR-II molecular fluorophores with enhanced fluorescent performance10.1021/jacs.7b10334 ↗
22. Molecular motion in aggregates: manipulating TICT for boosting photothermal theranostics10.1021/jacs.8b13889 ↗
23. A borondifluoride-complex-based photothermal agent with an 80% photothermal conversion efficiency for photothermal therapy in the NIR-II window10.1002/anie.202107836 ↗
24. Highly efficient photothermal nanoagent achieved by harvesting energy via excited-state intramolecular motion within nanoparticles10.1038/s41467-019-08722-z ↗
25. Photoinduced nonadiabatic decay-guided molecular motor triggers effective photothermal conversion for hyperthermia cancer therapy10.1002/anie.202002516 ↗
26. Biodegradable polymer with effective near-infrared-II absorption as a photothermal agent for deep tumor therapy10.1002/adma.202105976 ↗
27. NIR-II fluorescent brightness promoted by “Ring Fusion” for the detection of intestinal inflammation10.1002/chem.202101767 ↗
28. Boosting photothermal theranostics via TICT and molecular motions for photohyperthermia therapy of muscle-invasive bladder cancer
29. Constitutional isomerization enables bright NIR-II AIEgen for brain-inflammation imaging10.1002/adfm.201908125 ↗
30. Side chain engineering of semiconducting polymers for improved NIR-II fluorescence imaging and photothermal therapy
31. Rational design of high brightness NIR-II organic dyes with S-D-A-D-S structure10.1021/accountsmr.0c00114 ↗
32. A-DA′D-A structured organic phototheranostics for NIR-II fluorescence/photoacoustic imaging-guided photothermal and photodynamic synergistic therapy10.1021/acsami.1c22444 ↗
33. D-A-D organic small molecules with AIE effect for fluorescence imaging guided photothermal therapy10.1039/D2BM01912D ↗
34. Pitaya-inspired metal-organic framework nanozyme for multimodal imaging-guided synergistic cuproptosis, nanocatalytic therapy, and photothermal therapy10.1002/adhm.202402915 ↗
35. Development of D-A-D-type NIR-II photothermal agents for synergistic eradication of multidrug-resistant bacteria and promoting diabetic wound healing10.1002/adfm.202411986 ↗
36. Furan-modified thiadiazolo quinoxaline as an electron acceptor for constructing second near-infrared aggregation-induced emission fluorophores for beyond 1300 nm fluorescence/photoacoustic imaging and photothermal therapy10.1002/agt2.458 ↗
37. Phenylboronic acid-modified near-infrared region II excitation donor-acceptor-donor molecule for 2-deoxy-D-glucose improved starvation/chemo/photothermal combination therapy10.1002/adhm.202302099 ↗
38. Design of AIEgens for near-infrared IIb imaging through structural modulation at molecular and morphological levels10.1038/s41467-020-15095-1 ↗
39. Increasing molecular planarity through donor/side-chain engineering for improved NIR-IIa fluorescence imaging and NIR-II photothermal therapy under 1064 nm
40. Rationally manipulating molecular planarity to improve molar absorptivity, NIR-II brightness, and photothermal effect for tumor phototheranostics
41. Side-chain engineering of organic photothermal agents for boosting further red-shifted absorption and higher photothermal therapeutic effect10.1016/j.colsurfb.2023.113611 ↗
42. Enhanced photothermal therapy performance of D-A conjugated polymers based on [1,2,3] triazolo[4,5-g] quinoxaline by manipulating molecular motion10.1039/D3TB01438J ↗
43. Mechanistic connotations of restriction of intramolecular motions (RIM)10.1093/nsr/nwaa260 ↗
44. Integrating aggregation induced emission and twisted intramolecular charge transfer via molecular engineering10.1002/adfm.202311404 ↗
45. BOIMPY scaffold: accessing ultrahigh molar extinction coefficient AIEgen for SWIR imaging-guided photothermal cancer ablation10.1002/adfm.202411838 ↗
46. Molecular etching-derived high-brightness NIR-II gold nanoclusters for high-resolution bioimaging and photothermal therapy
47. π Bridge engineering-boosted dual enhancement of type-I photodynamic and photothermal performance for mitochondria-targeting multimodal phototheranostics of tumor10.1021/acsnano.3c06542 ↗
48. As aggregation-induced emission meets with noncovalent conformational locks: subtly regulating NIR-II molecules for multimodal imaging-navigated synergistic therapies